基于网络药理学与体内外模型探讨癫痫合剂抗癫痫的作用机制OA
Anti-Epileptic Effect and Mechanism of Dianxian Heji Based on Network Pharmacology and In Vivo and In Vitro Models
目的:本研究运用网络药理学方法结合体内外实验验证,以红藻氨酸(KA)诱导的大鼠癫痫模型和谷氨酸(L-Glu)诱导SH-SY5Y神经元细胞损伤模型阐明癫痫合剂抗癫痫作用及其主要机制.方法:通过数据库筛选癫痫合剂活性成分及潜在治疗靶点,构建蛋白互作(PPI)网络并分析核心靶点,进行GO和KEGG通路富集分析,采用Autodock Vina对核心成分与关键靶点进行分子对接.体内建立红藻氨酸大鼠癫痫模型,设正常对照组、模型对照组、癫痫合剂2、4 g/kg组及阳性对照卡马西平125 mg/kg组,观察癫痫合剂对大鼠脑电(EEG)、认知功能、海马神经元损伤及γ氨基丁酸/谷氨酸(GABA/Glu)等神经递质的影响.体外以谷氨酸9 mmol/L诱导SH-SY5Y细胞损伤进行机制研究,设空白对照组、模型对照组、阳性对照姜黄素 2.5 μmol/L 组及癫痫合剂 0.5、1 mg/mL组,采用CCK-8 法检测细胞活力;Annexin V-FITC/PI双染法检测细胞凋亡率;JC-1 探针检测线粒体膜电位变化;DCFH-DA探针检测细胞内ROS水平;Western blot法检测癫痫合剂对PI3K/AKT/mTOR通路相关蛋白磷酸化表达的影响.结果:网络药理学分析显示,癫痫合剂主要活性成分包括槲皮素、木犀草素、没食子酸、3,4,5-三甲氧基肉桂酸等,关键靶点包括mTOR、AKT1 和TP53 等.体内实验证实,癫痫合剂能明显抑制红藻氨酸诱导的癫痫发作(P<0.05 或P<0.01),改善认知障碍,保护海马神经元,升高GABA、5-HT、DA、NA/NE含量,降低Glu含量(P<0.05 或P<0.01).以谷氨酸诱导神经元细胞损伤模型,癫痫合剂0.5、1 mg/mL组显著提高SH-SY5Y细胞活力,降低细胞凋亡率和ROS水平,降低线粒体膜电位(P<0.05 或P<0.01),下调PI3K、AKT、mTOR蛋白磷酸化表达(P<0.05 或P<0.01).结论:癫痫合剂具有明确的抗癫痫及神经保护作用,其机制可能通过调控PI3K/AKT/mTOR信号通路,抑制谷氨酸诱导的神经元氧化应激与凋亡级联反应,并调节脑内GABA/Glu递质平衡,从而发挥整体抗癫痫作用.
Objective:This study aims to elucidate the anti-epileptic effect and primary mechanism of Dianxian Heji(癫痫合剂)in the kainic acid(KA)-induced rat epilepsy model and L-glutamic acid(L-Glu)-induced neuronal cell SH-SY5Y damage model by using network pharmacology combined with in vivo and in vitro experiment validation.Meth-ods:The active ingredients and potential therapeutic targets of Dianxian Heji were screened through databases to con-struct a protein-protein interaction(PPI)network and analyze the core targets,gene ontology(GO)and Kyoto Encyclo-pedia of Genes and Genomes(KEGG)pathway enrichment analysis were performed.The Autodock Vina was used to perform molecular docking between core ingredients and key targets.A KA-induced rat epilepsy model was established in vivo,and blank control group,model control group,Dianxian Heji groups(2 g/kg and 4 g/kg),and carbamazepine group(125 mg/kg,positive control)were set up.The effects of the Dianxian Heji on rats'electroencephalogram(EEG),cog-nitive function,hippocampal neuronal damage,and neurotransmitters such as gamma-aminobutyric acid(GABA)/Glu were observed.The mechanism of 9-mmol/L Glu-induced SH-SY5Y cell damage model was researched in vitro.Models were divided into a blank control group,a model control group,a curcumin group(2.5 μmol/L,positive control),and Dianxian Heji groups(0.5 and 1 mg/mL).Cell viability was assessed by cell counting kit-8(CCK-8)assay,apoptosis rate was detected by Annexin V-FITC/PI double staining,variation of mitochondrial membrane potential was detected by the JC-1 probe.Intracellular reactive oxygen species(ROS)level was detected by DCFH-DA probe,and the effect of Di-anxian Heji on the phosphorylation expressions of phosphatidylinositide 3-kinase(PI3K)/AKT/mammalian target of ra-pamycin(mTOR)pathway-related proteins was detected by Western blot.Results:Network pharmacology analysis showed that the primary active ingredients of the Dianxian Heji included quercetin,luteolin,gallic acid,3,4,5-trime-thoxycinnamic acid,etc.The key targets included mTOR,AKT1,TP53,mTOR,etc.In vivo experiments confirmed that the Dianxian Heji significantly inhibited KA-induced epileptic seizure(P<0.05 or P<0.01),improved cognitive impair-ment,protected hippocampal neurons,and corrected GABA/Glu neurotransmitter imbalance(P<0.05 or P<0.01).In a Glu-induced neuronal cell damage model,the Dianxian Heji significantly increased SH-SY5Y cell viability,reduced apop-tosis rate and ROS level,and improved mitochondrial membrane potential(P<0.05 or P<0.01).Western blot results showed that the Dianxian Heji significantly inhibited Glu-induced overactivation of the PI3K/AKT/mTOR pathway(P<0.05 or P<0.01).Conclusion:The Dianxian Heji has clear anti-epileptic and neuroprotective effects.Its mechanism may be related to regulating the PI3K/AKT/mTOR signaling pathway,inhibiting Glu-induced neuronal oxidative stress and apoptosis cascade,and regulating the GABA/Glu neurotransmitter balance in the brain,thereby exerting an overall anti-epileptic effect.
周文文;司丽君;郭君婷;赵婷婷;王守宝;斯拉甫·艾白;刘桂花
新疆医科大学药学院,乌鲁木齐 830011新疆维吾尔自治区药物研究院,乌鲁木齐 830002新疆维吾尔自治区药物研究院,乌鲁木齐 830002新疆维吾尔自治区药物研究院,乌鲁木齐 830002中国医学科学院协和药物研究所国家药物筛选中心,北京 100050新疆维吾尔自治区药物研究院,乌鲁木齐 830002新疆维吾尔自治区药物研究院,乌鲁木齐 830002||新疆医科大学药学院,乌鲁木齐 830011
癫痫合剂网络药理学氧化应激红藻氨酸神经保护线粒体磷酸肌醇-3激酶蛋白激酶雷帕霉素
Dianxian HejiNetwork pharmacologyOxidative stressKainic acidNeuroprotectionMitochondrionPI3KProtein kinaseRapamycin
《中药药理与临床》 2026 (2)
25-35,11
新疆维吾尔自治区重大科技专项项目(编号:2022A03017-5)中央级公益性科研院所基本科研业务费专项(编号:2023-RW360-01)新疆维吾尔自治区重大科技专项项目(编号:2022A03006-1).
评论